{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:39:43Z","timestamp":1790674783052,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"School of Medicine, Shahed University"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.biopha.2017.02.007","type":"journal-article","created":{"date-parts":[[2017,2,13]],"date-time":"2017-02-13T10:54:58Z","timestamp":1486983298000},"page":"1-9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"special_numbering":"C","title":["Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson\u2019s disease in the rat"],"prefix":"10.1016","volume":"89","author":[{"given":"Siamak","family":"Afshin-Majd","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keyhan","family":"Bashiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Kiasalari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tourandokht","family":"Baluchnejadmojarad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reza","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrdad","family":"Roghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.02.007_bib0005","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2741\/S415","article-title":"Parkinson's disease: a review","volume":"6","author":"Beitz","year":"2014","journal-title":"Front. Biosci. (Schol Ed.)"},{"key":"10.1016\/j.biopha.2017.02.007_bib0010","first-page":"749","article-title":"A systematic review of the worldwide prevalence and incidence of Parkinson's disease","volume":"94","author":"Muangpaisan","year":"2011","journal-title":"J. Med. Assoc. Thailand"},{"issue":"Suppl. 1","key":"10.1016\/j.biopha.2017.02.007_bib0015","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s10654-011-9581-6","article-title":"Epidemiology and etiology of Parkinson's disease: a review of the evidence","volume":"26","author":"Wirdefeldt","year":"2011","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0020","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1471-4159.2005.03000.x","article-title":"Ginkgo biloba affords dose-dependent protection against 6-hydroxydopamine-induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences","volume":"93","author":"Ahmad","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2017.02.007_bib0025","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s10571-015-0230-6","article-title":"Hypericum perforatum hydroalcoholic extract mitigates motor dysfunction and is neuroprotective in intrastriatal 6-hydroxydopamine rat model of Parkinson's disease","volume":"36","author":"Kiasalari","year":"2016","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0030","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s11064-015-1796-6","article-title":"Protective effect of oral hesperetin against unilateral striatal 6-hydroxydopamine damage in the rat","volume":"41","author":"Kiasalari","year":"2016","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0035","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1042\/BJ20150617","article-title":"Amyloid fibrils are the molecular trigger of inflammation in Parkinson's disease","volume":"471","author":"Gustot","year":"2015","journal-title":"Biochem. J."},{"key":"10.1016\/j.biopha.2017.02.007_bib0040","first-page":"51","article-title":"Extracellular alpha-synuclein?a possible initiator of inflammation in Parkinson's disease","volume":"71","author":"Ren","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.biopha.2017.02.007_bib0045","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.4103\/1673-5374.165228","article-title":"Transforming growth factor beta1-mediated anti-inflammation slows progression of midbrain dopaminergic neurodegeneration in Parkinson's disease?","volume":"10","author":"Spittau","year":"2015","journal-title":"Neural. Regen. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3389\/fnagi.2014.00036","article-title":"The emerging role of nutrition in Parkinson's disease","volume":"6","author":"Seidl","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0055","doi-asserted-by":"crossref","first-page":"10608","DOI":"10.3390\/ijms130810608","article-title":"Recent advances on the neuroprotective potential of antioxidants in experimental models of Parkinson's disease","volume":"13","author":"Koppula","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0060","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12906-015-0815-0","article-title":"Neuroprotective effect of Spirulina fusiform and amantadine in the 6-OHDA induced Parkinsonism in rats","volume":"15","author":"Chattopadhyaya","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2017.02.007_bib0065","first-page":"227","article-title":"Neuroprotective effect of thymoquinone, the nigella sativa bioactive compound, in 6-hydroxydopamine-induced hemi-parkinsonian rat model","volume":"13","author":"Sedaghat","year":"2014","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1196\/annals.1320.010","article-title":"Delaying the mitochondrial decay of aging with acetylcarnitine","volume":"1033","author":"Ames","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1432-1327.1999.00524.x","article-title":"Entry of [(1,2-13C2)acetyl]-L-carnitine in liver tricarboxylic acid cycle and lipogenesis: a study by 13C NMR spectroscopy in conscious freely moving rats","volume":"263","author":"Aureli","year":"1999","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.biopha.2017.02.007_bib0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ejphar.2010.09.085","article-title":"Cisplatin-induced cardiotoxicity: mechanisms and cardioprotective strategies","volume":"650","author":"El-Awady el","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0085","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1017\/S0007114511000493","article-title":"Mitochondrial dysfunction in the liver of type 2 diabetic Goto-Kakizaki rats: improvement by a combination of nutrients","volume":"106","author":"Hao","year":"2011","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.biopha.2017.02.007_bib0090","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.3390\/ijms13022078","article-title":"Neuroprotective effects of pre-treatment with l-carnitine and acetyl-L-carnitine on ischemic injury in vivo and in vitro","volume":"13","author":"Zhang","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0095","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.pbb.2011.09.002","article-title":"Acetyl-L-carnitine and alpha-lipoic acid affect rotenone-induced damage in nigral dopaminergic neurons of rat brain, implication for Parkinson's disease therapy","volume":"100","author":"Zaitone","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.02.007_bib0100","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.neulet.2015.08.044","article-title":"Histopathological and electrophysiological indices of rotenone-evoked dopaminergic toxicity: neuroprotective effects of acetyl-L-carnitine","volume":"606","author":"Sarkar","year":"2015","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.02.007_bib0105","doi-asserted-by":"crossref","first-page":"e41086","DOI":"10.1371\/journal.pone.0041086","article-title":"Neuroprotective effects of N-acetyl-cysteine and acetyl-L-carnitine after spinal cord injury in adult rats","volume":"7","author":"Karalija","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.02.007_bib0110","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1023\/A:1019800703683","article-title":"Acetyl-L-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels","volume":"27","author":"Dhitavat","year":"2002","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0115","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2016.06.046","article-title":"Acetyl-l-carnitine restores synaptic transmission and enhances the inducibility of stable LTP after oxygen-glucose deprivation","volume":"332","author":"Kocsis","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.02.007_bib0120","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"key":"10.1016\/j.biopha.2017.02.007_bib0125","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1007\/s12035-014-8771-0","article-title":"Carnosine exerts neuroprotective effect against 6-hydroxydopamine toxicity in hemiparkinsonian rat","volume":"51","author":"Afshin-Majd","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0130","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0031-9384(02)00753-9","article-title":"Efficacy of elevated body swing test in the early model of Parkinson's disease in rat","volume":"76","author":"Roghani","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2017.02.007_bib0135","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","article-title":"A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding","volume":"72","author":"Bradford","year":"1976","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.02.007_bib0140","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/0003-2697(68)90092-4","article-title":"Estimation of total protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent","volume":"25","author":"Sedlak","year":"1968","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.biopha.2017.02.007_bib0145","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","article-title":"Tissue sulfhydryl groups","volume":"82","author":"Ellman","year":"1959","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.biopha.2017.02.007_bib0150","series-title":"CRC Handbook of Methods for Oxygen Radical Research","first-page":"283","article-title":"Catalase activity","author":"Claiborne","year":"1985"},{"key":"10.1016\/j.biopha.2017.02.007_bib0155","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuro.2013.03.004","article-title":"Neuroprotective effect of sulforaphane in 6-hydroxydopamine-lesioned mouse model of Parkinson's disease","volume":"36","author":"Morroni","year":"2013","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2017.02.007_bib0160","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11062-016-9586-6","article-title":"Neuroprotective and antiapoptotic potential of trigonelline in a striatal 6-hydroxydopamine rat model of Parkinson\u2019s disease","volume":"48","author":"Mirzaie","year":"2016","journal-title":"Neurophysiology"},{"key":"10.1016\/j.biopha.2017.02.007_bib0165","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11011-014-9604-6","article-title":"The neuroprotective potential of sinapic acid in the 6-hydroxydopamine-induced hemi-parkinsonian rat","volume":"30","author":"Zare","year":"2015","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.biopha.2017.02.007_bib0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.brainres.2014.05.045","article-title":"Differential effects of intrastriatal 6-hydroxydopamine on cell number and morphology in midbrain dopaminergic subregions of the rat","volume":"1574","author":"Healy-Stoffel","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0175","doi-asserted-by":"crossref","first-page":"e101468","DOI":"10.1371\/journal.pone.0101468","article-title":"Spinal cord stimulation exerts neuroprotective effects against experimental Parkinson's disease","volume":"9","author":"Shinko","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.biopha.2017.02.007_bib0180","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/exnr.1998.6848","article-title":"Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat","volume":"152","author":"Kirik","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0185","first-page":"1145","article-title":"Berberine chloride pretreatment exhibits neuroprotective effect against 6-hydroxydopamine-induced neuronal insult in rat","volume":"14","author":"Negahdar","year":"2015","journal-title":"Iran. J. Pharm. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neulet.2010.06.038","article-title":"Neuroprotective effect of silymarin in 6-hydroxydopamine hemi-parkinsonian rat: involvement of estrogen receptors and oxidative stress","volume":"480","author":"Baluchnejadmojarad","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.02.007_bib0195","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson's disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0200","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainres.2013.01.054","article-title":"Alpha-lipoic acid protects against 6-hydroxydopamine-induced neurotoxicity in a rat model of hemi-parkinsonism","volume":"1505","author":"Jalali-Nadoushan","year":"2013","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0205","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-8993(00)03296-0","article-title":"Neuroprotective effect of vitamin E on the early model of Parkinson's disease in rat: behavioral and histochemical evidence","volume":"892","author":"Roghani","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.expneurol.2006.12.016","article-title":"Effects of 6-hydroxydopamine-induced severe or partial lesion of the nigrostriatal pathway on the neuronal activity of pallido-subthalamic network in the rat","volume":"205","author":"Breit","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0006-8993(97)01100-1","article-title":"Adenoviral vector-mediated GDNF gene therapy in a rodent lesion model of late stage Parkinson's disease","volume":"777","author":"Lapchak","year":"1997","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.physbeh.2004.04.005","article-title":"Evaluation of functional asymmetry in rats with dose-dependent lesions of dopaminergic nigrostriatal system using elevated body swing test","volume":"82","author":"Baluchnejadmojarad","year":"2004","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.biopha.2017.02.007_bib0225","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bbr.2011.12.007","article-title":"Sensorimotor assessment of the unilateral 6-hydroxydopamine mouse model of Parkinson's disease","volume":"230","author":"Glajch","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2011.03.031","article-title":"Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion","volume":"222","author":"Hsieh","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0235","first-page":"689","article-title":"Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions","volume":"18","author":"Schwarting","year":"1997","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.biopha.2017.02.007_bib0240","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1582-4934.2008.00390.x","article-title":"Combined R-alpha-lipoic acid and acetyl-L-carnitine exerts efficient preventative effects in a cellular model of Parkinson's disease","volume":"14","author":"Zhang","year":"2010","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.biopha.2017.02.007_bib0245","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jneumeth.2006.07.006","article-title":"Use of the narrow beam test in the rat, 6-hydroxydopamine model of Parkinson's disease","volume":"159","author":"Allbutt","year":"2007","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.biopha.2017.02.007_bib0250","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2174\/1871527314666150225124928","article-title":"Inflammatory and cell death pathways in brain and peripheral blood in Parkinson's disease","volume":"14","author":"Macchi","year":"2015","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.biopha.2017.02.007_bib0255","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1271\/bbb.110842","article-title":"Isoliquiritigenin isolated from licorice Glycyrrhiza uralensis prevents 6-hydroxydopamine-induced apoptosis in dopaminergic neurons","volume":"76","author":"Hwang","year":"2012","journal-title":"Biosci. Biotechnol. Biochem."},{"key":"10.1016\/j.biopha.2017.02.007_bib0260","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1179\/174313208X362479","article-title":"Neuronal death after peripheral nerve injury and experimental strategies for neuroprotection","volume":"30","author":"Hart","year":"2008","journal-title":"Neurol. Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0265","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s12035-013-8498-3","article-title":"Food, nutrigenomics, and neurodegeneration-neuroprotection by what you eat!","volume":"48","author":"Virmani","year":"2013","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0270","article-title":"Novel tactics for neuroprotection in Parkinson's disease: role of antibiotics, polyphenols and neuropeptides","author":"Reglodi","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/01.mjt.0000174353.28012.a7","article-title":"Neuroprotective therapy in Parkinson disease","volume":"13","author":"Chen","year":"2006","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.biopha.2017.02.007_bib0280","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.neuroscience.2009.02.086","article-title":"Acetyl-l-carnitine (ALCAR) prevents hypobaric hypoxia-induced spatial memory impairment through extracellular related kinase-mediated nuclear factor erythroid 2-related factor 2 phosphorylation","volume":"161","author":"Barhwal","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopha.2017.02.007_bib0285","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1038\/sj.npp.1301381","article-title":"Iptakalim alleviates rotenone-induced degeneration of dopaminergic neurons through inhibiting microglia-mediated neuroinflammation","volume":"32","author":"Zhou","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopha.2017.02.007_bib0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.expneurol.2005.10.034","article-title":"Role of ICAM-1 in persisting inflammation in Parkinson disease and MPTP monkeys","volume":"197","author":"Miklossy","year":"2006","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0295","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-007-9070-6","article-title":"Divergent roles for tumor necrosis factor-alpha in the brain","volume":"2","author":"Sriram","year":"2007","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0300","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0169-328X(98)00066-7","article-title":"The NF-kappaB\/Rel family of proteins mediates Abeta-induced neurotoxicity and glial activation","volume":"57","author":"Bales","year":"1998","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.biopha.2017.02.007_bib0305","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/j.1749-6632.2000.tb06192.x","article-title":"Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP","volume":"899","author":"Grunblatt","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.toxlet.2015.11.007","article-title":"Inflammatory and fibrotic processes are involved in the cardiotoxic effect of sunitinib: protective role of L-carnitine","volume":"241","author":"Blanca","year":"2016","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.biopha.2017.02.007_bib0315","doi-asserted-by":"crossref","first-page":"308654","DOI":"10.1155\/2014\/308654","article-title":"Evidence of inflammatory system involvement in Parkinson's disease","volume":"2014","author":"Chao","year":"2014","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.biopha.2017.02.007_bib0320","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.neulet.2008.06.040","article-title":"Serum interleukin (IL-2, IL-10 IL-6, IL-4), TNFalpha, and INFgamma concentrations are elevated in patients with atypical and idiopathic parkinsonism","volume":"441","author":"Brodacki","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.biopha.2017.02.007_bib0325","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s12031-011-9500-z","article-title":"17beta-estradiol protects dopaminergic neurons in organotypic slice of mesencephalon by MAPK-mediated activation of anti-apoptosis gene BCL2","volume":"45","author":"Wang","year":"2011","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.biopha.2017.02.007_bib0330","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.expneurol.2008.12.019","article-title":"Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4\/NF-kappaB pathway","volume":"216","author":"Chen","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2017.02.007_bib0335","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.phymed.2008.10.008","article-title":"Herbal melanin activates TLR4\/NF-kappaB signaling pathway","volume":"16","author":"Oberg","year":"2009","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2017.02.007_bib0340","first-page":"519615","article-title":"Neuroprotective Properties of a Standardized Extract from Myracrodruon urundeuva Fr. All. (Aroeira-Do-Sertao), as Evaluated by a Parkinson's Disease Model in Rats","volume":"2014","author":"Calou","year":"2014","journal-title":"Parkinsons Dis."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216311842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332216311842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:03:42Z","timestamp":1760094222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332216311842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":68,"alternative-id":["S0753332216311842"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.007","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetyl-l-carnitine protects dopaminergic nigrostriatal pathway in 6-hydroxydopamine-induced model of Parkinson\u2019s disease in the rat","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}